According to the UN, the Earth is home to more than 8 billion inhabitants, with the global population expected to reach 9.8 billion by 2050. The number of adults aged 65 and over is also expected to increase, encompassing more than 25 per cent of the population in Europe, North America, and Asia-Pacific.
According to the UN, the Earth is home to more than 8 billion inhabitants, with the global population expected to reach 9.8 billion by 2050. The number of adults aged 65 and over is also expected to increase, encompassing more than 25 per cent of the population in Europe, North America, and Asia-Pacific.
An ageing world
The world's population is getting older because of a decline in fertility and infant mortality, and an improvement in life expectancy owing to advances in medical care, hygiene, and diet. This demographic shift is one of the defining megatrends of the 21st century.
The global population aged over 65 is projected to double over the next 30 years — from approximately 750 million today to over 1.5 billion by 2050. In Japan, Italy, and Germany, people aged 65 and over already represent more than 20% of the population.
The longevity economy
This demographic shift presents extraordinary opportunities. The megatrend of an ageing population has led to the development of products and services that cater to older adults' health and wellness.
As Simone Gibertoni, CEO of Clinique La Prairie, notes: "The global wellness economy has ballooned to more than $6 trillion in value and, within that, the longevity-focused market is forecast to reach around $610 billion by 2026. This 'longevity economy' — affluent, health-conscious individuals seeking to extend their healthy years — is driving growth across continents."
Healthspan, not just lifespan
Citizens increasingly consider health span — how long they remain healthy, active, and free from serious illness — as central to their aspirations, not simply total years lived. This mindset is fuelling demand across multiple sectors:
- Preventive diagnostics: biological age testing, multi-omics profiling, continuous glucose monitors
- Longevity clinics: premium health optimisation centres offering personalised protocols
- Nutraceuticals: evidence-based supplements targeting NAD+, senescence, and inflammation
- Wearable technology: continuous health monitoring for personalised intervention
- Regenerative medicine: stem cell therapies, plasma exchange, and tissue engineering
"Health is sometimes called the new wealth, and we see that mindset fuelling demand for longevity-focused solutions globally." — Longevity World Group
The science is catching up
What once seemed like science fiction — reversing biological age, extending healthy lifespan by decades, eliminating age-related disease — is increasingly supported by peer-reviewed research. Senolytics, epigenetic reprogramming, and NAD+ metabolism have moved from laboratory curiosities to clinical trials.
The convergence of AI-powered diagnostics, multi-omics data, and precision medicine is enabling increasingly personalised approaches to longevity optimisation. The question is shifting from if we can extend healthy human lifespan to when these interventions will become widely accessible.
Implications for policy and investment
Governments and institutional investors are beginning to recognise longevity science as a strategic priority. Nations that invest in healthy ageing will benefit from more productive older populations, reduced healthcare burden, and competitive advantage in the growing longevity economy. The economics are compelling: every year of healthy life added to a population represents enormous social and economic value.
